JUN 27, 2019 10:50 AM PDT

Remote Controlled Drug Delivery?

WRITTEN BY: Nouran Amin

According to the CDC, chronic diseases although the most common are preventable of all medical problems. Chronic diseases ranging from arthritis to heart disease and diabetes leave its patients with the inconveniences of the daily regimen of pills and scheduled medication dosage. Now, researchers from Houston Methodist have aimed to solve this problem by implanting a battery-powered grape-sized implant that is remotely controlled and made with similar technology used in the silicon semiconductor industry.

Using a nanochannel delivery system (nDS) controlled via Bluetooth technology, two dosages of drug delivery were successfully demonstrated without the need for pumps, valves, or a power supply and researchers are now planning to test in space.

"We see this universal drug implant as part of the future of health care innovation. Some chronic disease drugs have the greatest benefit of delivery during overnight hours when it's inconvenient for patients to take oral medication. This device could vastly improve their disease management and prevent them from missing doses, simply with a medical professional overseeing their treatment remotely," said Alessandro Grattoni, Ph.D., corresponding author and chair of the department of nanomedicine at Houston Methodist Research Institute.

The proof-of-concept paper was published in Lab on a Chip and describes how the device is implanted under the skin and utilizes a nanofluidic membrane that can deliver drugs tailored to each patient with correct dosage and schedule. The implant, which contains a microchip that is Bluetooth enabled and relies on wireless communication, can deliver drugs up to a year before a refill is needed. The microchip essentially is programmed for different drug release settings -- standard, decreased and increased.

Researchers are hopeful that their study may someday be the building ground for advancing telemedicine and helping clinicians treat their patients better.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
APR 15, 2020
Immunology
APR 15, 2020
Why More Men than Women Die from COVID-19
As of April 9th, over 60% of deaths from COVID-19 in New York state were men. Meanwhile, as of April 6, 82% of patients ...
APR 21, 2020
Immunology
APR 21, 2020
Sino Biological Focuses on Serological Studies of COVID-19
April 17, 2020, Sino Biological announced this week that the company launched the world’s first coronavirus antige ...
APR 17, 2020
Chemistry & Physics
APR 17, 2020
Fish Tank Chemicals Aren't COVID-19 Medication, Says FDA
While the medical community is scrambling to find the proper medications for Sars-CoV-02 infection, a significant portio ...
APR 12, 2020
Drug Discovery & Development
APR 12, 2020
Can Spider-Venom Alleviate Pain?
Can spider venom offer pain relief? Apparently, yes! According to researchers at University of Queensland, compounds iso ...
APR 30, 2020
Cancer
APR 30, 2020
A New microRNA for the Cancer Fighting Toolkit
MiRNAs are small snippets of genetic information that regulate gene expression thought to be able to regulate up to 60% ...
MAY 23, 2020
Cancer
MAY 23, 2020
A New Biomarker to Identify a Triple Negative Breast Cancer Prognosis
Breast cancer, one of the most common cancers in the world, are commonly separated into one of several sub-types. These ...
Loading Comments...